Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

about

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

Item

http://www.wikidata.org/entity/Q55190915

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

@en

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

@nl

type

Item

label

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

@en

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

@nl

prefLabel

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

@en

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

@nl

P1476

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent

@en

P2093

Mariam M Tadros

http://www.w3.org/2001/XMLSchema#string

Marwa M Safar

http://www.w3.org/2001/XMLSchema#string

Mohamed M Elmazar

http://www.w3.org/2001/XMLSchema#string

Nermeen Ashoush

http://www.w3.org/2001/XMLSchema#string

Shereen Mowaka

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications

Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease

Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes

Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma

Drug repositioning: identifying and developing new uses for existing drugs

Data supporting the rat brain sample preparation and validation assays for simultaneous determination of 8 neurotransmitters and their metabolites using liquid chromatography-tandem mass spectrometry.

Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.

Quantitative analysis of phenibut in rat brain tissue extracts by liquid chromatography-tandem mass spectrometry.

Possible mechanisms relating diet and risk of colon cancer.

LC-MS/MS method for the determination of pitolisant: application to rat pharmacokinetic and brain penetration studies.

P304

8959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-27395-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29895906

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5997767

http://www.w3.org/2001/XMLSchema#string